【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2013 14
2.2.1 AstraZeneca to Acquire Remaining 50% Interest in Diabetes Joint Venture from Bristol-Myers Squibb for US$4.3 Billion 14
2.2.2 Johnson & Johnson Prices Public Offering of Notes for US$3.5 Billion 15
2.2.3 OncoMed Pharma Enters into Co-Development Agreement with Celgene 16
2.2.4 Thermo Fisher Scientific Completes Public Offering of Notes for US$3.2 Billion 17
2.2.5 Genmab Expands Licensing Agreement With Janssen Biotech 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2013 21
3.1.1 Top M&A Deals in December 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2013 – December 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2013 24
3.2.1 Top Equity Offering Deals in December 2013 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2013 – December 2013 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2013 27
3.3.1 Top PE/VC Deals in December 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2013 30
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2013–December 2013 32
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2013–December 2013 33
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2013 – December 2013 36
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2013 37
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2013 38
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 39
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2013 – December 2013 41
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2013 – December 2013 42
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 44
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2013 48
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2013 49
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2013 50
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2013 50
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2013 – December 2013 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2013 – December 2013 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 57
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2013 59
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2013 63
6.2.1 Central Nervous System – Deals of the Month 65
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2013 70
6.4.1 Metabolic Disorders – Deal of the Month 72
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2013 73
6.5.1 Immunology – Dealsof the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2013 76
6.6.1 Cardiovascular – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, December 2013 78
6.7.1 Respiratory – Deals of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2013 83
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 91
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2013 – December 2013 91
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2013 – December 2013 93
9 Further Information 95
9.1 Methodology 95
9.2 About GlobalData 96
9.3 Disclosure information 97
9.4 Disclaimer 97
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
■ 発行日：2014年1月27日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163519
■ 調査対象地域：グローバル
- 液化天然ガス（LNG）インフラの世界市場におけるトップ15企業分析2016This independent 157 page analysis guarantees you will remain better informed than your competitors. It contains 113 tables and figures examining the competitor positioning for the 15 largest companies in LNG infrastructure in 2016 in terms of CAPEX on onshore liquefaction terminals, their operations and where they intend to expand. Likely future entrants into the market are also examined in equal …
- カニューレの世界市場2016-2020About Cannulae Cannulae is a flexible tube that is inserted into an artery or vein for different medical purposes such as the administration or removal of fluid from the body intravenously. The condition and medical purpose help determine the cannulas' size ranging from 14 guage to 22 gauge with different color codes. The administration of fluid depends on the size of the gauge: smaller the gauge, …
- 世界の軍事用電子光学/赤外線（EO/IR）市場（2014-2024）Product Synopsis This report is the result of SDI's extensive market and company research covering the global military EO/IR Systems industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news. Introduction and Landscape Why wa …
- ユーバイオティクスの世界市場分析：製品別（プロバイオティクス、プレバイオティクス、有機酸、エッセンシャルオイル）、形状別（液体、固体）、用途別（腸の健康、免疫、産出）、エンドユーザー別（ウシ、家禽、豚、水産物）、セグメント予測、2014-2025The global eubiotics market is expected to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing meat consumption coupled with rising awareness regarding meat quality is expected to drive global eubiotics market growth. Eubiotics influence the gut microflora and confer health benefits on the host. They maintain a correct balance of the microbial activity in …
- 非血管ステントの世界市場分析および予測MediPoint: Non-Vascular Stents - Global Analysis and Market Forecasts Summary Non-vascular stent technology has evolved over the years such that these devices are routinely used in clinical practice for different indications. Although it is a mature market, both short and long-term complications associated with non-vascular stents continue to persist. This report focuses on four market categories …
- 販売実績管理（SPM）ソリューションの世界市場：インセンティブ/報酬管理、テリトリー管理、販売計画およびモニタリング、販売分析The increasing business progressions across organizations are significantly transforming the operational patterns for organizations worldwide. This has invariably led to the obligatory need to drive sales so as to derive more revenues for the company through enhanced customer engagement. With the definite realization that boosted sales force form the core valuable asset for organizations that defi …
- 解凍装置の世界市場予測（～2022年）：種類、サンプル（血、血漿、RBC、血小板、全血、胎芽、精液）、エンドユーザーThe global thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices. The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmen …
- カーボンブラック(BC)の世界市場予測Carbon Black (BC) 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about carbon black market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical …
- グローバルにおける農業用機械・林業用機械市場（～2019）The industry report Global Agricultural and Forestry Machine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for agricultural and forestry machines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for ind …
- フィットネス及びスポーツ向けウェアラブル端末の世界市場About Smart Wearable Fitness and Sports Device and Services A smart wearable fitness and sports device is a device that is worn or attached to a user's body while on use. This device is portable and performs similar functions to that of smartphones and tablets. Important features of this device include real-time fitness monitoring, heart-rate monitoring, sleep statistics, counts the amount of calo …
- Shanghai Aohua Photoelectricity Endoscope Co.,Ltd：市場シェア分析Shanghai Aohua Photoelectricity Endoscope Co.,Ltd Market Share Analysis Summary GlobalData’s new report, “Shanghai Aohua Photoelectricity Endoscope Co.,Ltd Market Share Analysis” provides in-depth information on Shanghai Aohua Photoelectricity Endoscope Co.,Ltd’s market position in the flexible endoscopes market. The report also provides data and information on the overall competitive landscape wi …
- 世界の前立腺がん治療薬市場予測と分析PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022 Summary GlobalData's report "PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022", provides comprehensive information on prostate cancer therapeutics, highlighting the treatment guidelines and identifies and analyses the key trends shaping and driving the market. The report analyses the trea …
- ALT/SGPTの市場別検査数および販売予測（2013-2018/体外診断/世界主要国）This new report from Venture Planning Group provides analysis of ALT/SGPT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories PO …
- インドの鉄鋼市場2016-2020About Steel Industry Steel is composed of iron, carbon, metal impurities, and alloying elements that determine its chemical and physical properties. Based on its properties, steel is classified into carbon steel, alloy steel, and stainless steel. It has numerous advantages such as strength, durability, corrosion resistance, hardening ability, formability, welding ability, and ductility. Technavio’ …
- Atopic Dermatitis：グローバル臨床試験レビューH1, 2013Atopic Dermatitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H1, 2013" provides data on the Atopic Dermatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atopic Dermatitis. It includes an overview of the trial numbers and their recruitment s …
